Publication Name	World Journal of Methodology
Manuscript ID	100490
Country	United States

Received	2024-08-29 01:50
Peer-Review Started	2024-08-18 05:01
To Make the First Decision
Return for Revision	2024-11-22 12:38
Revised	2024-12-14 20:32
Second Decision	2024-12-20 03:03
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-12-20 09:55
Articles in Press	2024-12-20 09:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-12-27 03:12
Publish the Manuscript Online	2025-03-06 10:23

ISSN	2222-0682 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Cardiac & Cardiovascular Systems
Manuscript Type	Opinion Review
Article Title	Echo contrast medium: How the use of contrast echocardiography (ultrasound contrast agents) can improve patient care
Manuscript Source	Invited Manuscript
All Author List	Kevan English
Funding Agency and Grant Number
Corresponding Author	Kevan English, MD, Department of Internal Medicine, University of Nebraska Medical Center College of Medicine, S 42nd & Emile St, Omaha, NE 68198, United States. keenglish@unmc.edu
Key Words	Ultrasound contrast agents; Echocardiography; Myocardial perfusion; Ultrasound; Left ventricle; Optison; Definity; Sonazoid; Lumason
Core Tip	The use of ultrasound contrast agents (UCAs) during resting echocardiography can improve diagnostic accuracy by adequately assessing left ventricular (LV) function. Compared to standard echocardiograms, UCAs, when used, allow physicians to better assess regional wall motion abnormalities and LV ejection fraction. As a result, patients with LV apex disease can be accurately diagnosed without additional imaging. This consequently shortens hospital stays and improves patient outcomes.
Publish Date	2025-03-06 10:23
Citation	<p>English K. Echo contrast medium: How the use of contrast echocardiography (ultrasound contrast agents) can improve patient care. <i>World J Methodol</i> 2025; 15(3): 100490</p>
URL	https://www.wjgnet.com/2222-0682/full/v15/i3/100490.htm
DOI	https://dx.doi.org/10.5662/wjm.v15.i3.100490

Full Article (PDF)	WJM-15-100490-with-cover.pdf
Manuscript File	100490_Auto_Edited_012745.docx
Answering Reviewers	100490-answering-reviewers.pdf
Audio Core Tip	100490-audio.m4a
Conflict-of-Interest Disclosure Form	100490-conflict-of-interest-statement.pdf
Copyright License Agreement	100490-copyright-assignment.pdf
Peer-review Report	100490-peer-reviews.pdf
Scientific Misconduct Check	100490-scientific-misconduct-check.png
Scientific Editor Work List	100490-scientific-editor-work-list.pdf
CrossCheck Report	100490-crosscheck-report.pdf